623588-30-7 Usage
Uses
Used in Medicinal Chemistry:
TERT-BUTYL 4-(5-FORMYL-2-THIENYL)PIPERAZINE-1-CARBOXYLATE is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and functional groups make it a promising candidate for the development of new drugs with diverse therapeutic applications.
Used in Drug Discovery:
TERT-BUTYL 4-(5-FORMYL-2-THIENYL)PIPERAZINE-1-CARBOXYLATE is used as a potential lead compound in drug discovery. Its bioactivity and diverse pharmacological properties make it a valuable tool for identifying new therapeutic agents and advancing the development of novel treatments for various diseases.
Used in Pharmaceutical Industry:
TERT-BUTYL 4-(5-FORMYL-2-THIENYL)PIPERAZINE-1-CARBOXYLATE is used as a key component in the formulation of pharmaceutical products. Its potential applications in medicinal chemistry and drug discovery make it an important asset for the development of innovative and effective treatments in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 623588-30-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,3,5,8 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 623588-30:
(8*6)+(7*2)+(6*3)+(5*5)+(4*8)+(3*8)+(2*3)+(1*0)=167
167 % 10 = 7
So 623588-30-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O3S/c1-14(2,3)19-13(18)16-8-6-15(7-9-16)12-5-4-11(10-17)20-12/h4-5,10H,6-9H2,1-3H3
623588-30-7Relevant articles and documents
PYRAZOLOPYRIDINE DERIVATIVES AS ANTICANCER AGENT
-
, (2011/05/05)
The present invention concerns compounds of following general formula (I): (Formula I) and their pharmaceutically acceptable salts, their method of preparation and their uses, notably as anticancer agent.
NOVEL COMPOUNDS
-
Page/Page column 107, (2008/12/06)
There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.